What Comes Next? How dTMS Helps Reclaim Purpose After Depression

Why real healing isn’t just about feeling less pain – it’s about building a life worth living

By Jess Wight | August 20, 2026

“I think rather than the word ‘recovery’, it’s more ‘discovery’… it’s a journey of discovery.”

A patient recalling their journey of recovery from depression in a 2023 lived-experience review

For decades, the benchmark for successful depression treatment has been deceptively simple: reduce the symptoms. We measure success by what disappears – less sadness, less fatigue, fewer sleepless nights, less emotional pain. But anyone who has emerged from a severe depressive episode knows that the absence of suffering is not necessarily the same as the presence of a meaningful life. The darkness can lift without revealing where to go next.

That distinction is at the heart of an intriguing 2024 study examining the effects of deep transcranial magnetic stimulation (dTMS) in people with Major Depressive Disorder (MDD). dTMS is a non-invasive form of brain stimulation that has emerged as an important treatment option for depression, particularly for people who have not responded adequately to conventional treatments. The treatment uses magnetic pulses to stimulate specific brain regions involved in mood regulation, without the need for medication or surgery.

Depression can be difficult to treat, particularly for people who do not respond well to traditional treatments such as medication or psychotherapy. In recent years, dTMS has emerged as a promising non-invasive treatment option, and has been widely studied for its effectiveness in treating depression.

A 2020 systematic review and meta-analysis examined nine studies and found evidence supporting both efficacy and tolerability of dTMS among patients with depression. More recently, a 2024 systematic review focusing on randomized controlled trials included five studies and found that patients receiving active dTMS had significantly higher response and remission rates than those receiving control treatments.

Together, these reviews add to a growing body of research demonstrating the clinical efficacy and safety of dTMS, suggesting that it is an effective treatment option for depression, particularly when conventional treatments have been unsuccessful.

Across all the studies included in these reviews, the effectiveness of dTMS has been assessed using well-documented measures of depression, with the Hamilton Depression Rating Scale (HDRS) being one of the most commonly used. Other measures, including the Beck Depression Inventory (BDI), have also been used, allowing researchers to consistently assess changes in depressive symptoms across clinical trials.

Although decades of research show both the HDRS and the BDI to be reliable and established methods of assessing changes in depressive symptoms, they may not capture the full picture of recovery. These measures are primarily focused on the presence and severity of negative symptoms associated with depression, rather than positive aspects of psychological wellbeing. This creates an important limitation when interpreting what ‘successful’ treatment actually means. A person may score lower on a depression scale because their sadness, fatigue, or sleep difficulties have improved, while still struggling to find meaning, direction or motivation in their life.

This is where the 2024 dTMS study becomes particularly interesting. Alongside conventional measures of depression, the researchers examined Purpose in Life (PIL) – a measure that captures whether a person experiences their life as meaningful, purposeful, and worth pursuing.

The PIL measure was developed in the 1960s by psychologists James Crumbaugh and Leonard Maholick, drawing on Viktor Frankl’s work on meaning and purpose. The 20-item measure asks people to rate aspects of their lives including their sense of direction, goals, enthusiasm for the future, and whether life feels worthwhile and meaningful. Unlike conventional depression scales, PIL therefore asks a subtly different question. Rather than focusing only on whether something negative has diminished, it asks whether something positive has returned.

The researchers of the 2024 study found that after a 36-session course of dTMS, participants showed significant improvements not only in depressive symptoms, but also in their reported sense of purpose. This does not prove that dTMS itself restored purpose, but it suggests that changes in purpose may accompany the reduction of depressive symptoms, and raises the possibility that recovery involves more than simply becoming less depressed.

By targeting deeper neural circuits involved in reward, motivation, and executive functioning, dTMS appears to do more than quiet emotional pain: it helps reactivate the brain’s capacity for engagement. When depression lifts, it often leaves behind a cognitive and emotional vacuum. dTMS helps bridge this gap by stimulating the pathways responsible for goal-directed behavior and emotional resonance. Rather than simply returning a patient to a neutral, symptom-free baseline, this neural reactivation provides the neurological foundation needed to re-engage with personal goals, reconnect with personal relationships, and actively rebuild a meaningful life.

Part of the journey to recovery from depression is an aspect of grief. The unexpected feeling of loss can be a confusing time for individuals transitioning to a new space that was once filled with depressive symptoms. We often imagine getting better as simply feeling less pain, but research suggests that recovery can also involve reconstructing a sense of identity. Depression can become deeply woven into how we understand ourselves, and so when it begins to recede, people can often be left questioning who they are without it.

A 2026 qualitative study of people with recurrent of depression described personal recovery as a process of self-discovery. Part of that process involved developing a deeper understanding of themselves, reconnecting with their desires and needs, and importantly, letting go of the identity of being “a depressed person”.

This sense of letting go can be surprisingly painful. When someone has lived with depression for a long time, it can become familiar. It may shape routines, expectations, and relationships, and a person’s understanding of themselves. For some people, this may help explain why recovery can feel unexpectedly complicated. Even when someone desperately wants to escape depression, they may still miss the certainty of what was familiar. They may not miss being depressed so much as missing knowing exactly who they were when they were depressed.

This isn’t simply an idea pulled from personal stories. A systematic review published this year reviewed 27 studies representing the experiences of more than 900 people recovering from depression, identifying ‘reconstructing the self’ as a major theme of recovery. The researchers found that recovery involved much more than symptom reduction; people described having to rebuild their sense of self, autonomy, meaning, and connection.

Another study, based on interviews with people who had been treated for depression, described recovery as a “transformation of the experience of the depressed self.” Participants didn’t simply become symptom-free. They developed greater self-acceptance, self-understanding, agency, and a new way of making sense of their own stories.

There can be grief in this transition. It is possible for a person to be profoundly grateful to be getting better and still miss the person they were when depression was a part of their identity. Missing what is familiar doesn’t mean you want to go back. Sometimes it simply means learning to say goodbye to a version of yourself that, for a long time, was all they knew.

This is perhaps one of the quieter challenges of recovery: not only learning how to live without depression but learning to live as someone who no longer needs depression to explain the person that they are.

Research suggests that this process isn’t about returning to the person an individual was prior to being depressed either. Recovery can mean creating a new relationship with past experiences, integrating what happened rather than erasing it. As researchers in one recent study described, identity reconstruction in recovery isn’t necessarily a return to a previous ‘normal’; it is the development of a new way of understanding oneself and their story.

“After each depression, life returns and is reborn, and life returns and takes on meaning.”

A participant in a 2023 study reflecting on their experience of recovering from multiple episodes of depression

This raises a deeper question about what we mean when we say someone has “recovered” from depression. If recovery involves not only the disappearance of symptoms but the reconstruction of identity, purpose, and meaning, then perhaps the brain changes accompanying treatment deserve attention too.

This is precisely where the neurobiological data from the dTMS study becomes so compelling. Rather than just silencing depressive thoughts, the treatment appears to support the physical foundation necessary for this identity shift.

Researchers went one step further than most other studies examining dTMS as a treatment for depression. The researchers also examined changes in brain activity using quantitative electroencephalography (QEEG) and event-related potentials (ERPs). They observed changes in several EEG and ERP characteristics following treatment, including resting-state delta/beta activity and P200 latency. In doing so, the study begins to connect two levels of recovery that are often discussed separately: the subjective experience of finding purpose again and measurable neurophysiological changes occurring alongside it.

The implications are worth paying attention to. If depression treatment is ultimately about more than simply extinguishing symptoms, then perhaps recovery should be measured by more than what a person no longer feels. It should also account for what they are able to feel, pursue, and imagine again.

Beyond clearing the fog of depression, recovery is ultimately about what takes its place. By demonstrating that dTMS can support both the biological rebuilding of the brain and the emotional return of purpose, recent research points toward a fundamentally higher standard for treatment. True healing isn’t just about surviving the day, it is about regaining the agency, meaning, and connection that makes living worthwhile.